Since launching its pilot program in June 2020, Promise Fund has already provided nearly 10,000 screenings and 5,000 Pap ...
GT101 autologous TIL therapy in patients with recurrent and metastatic cervical cancer: A phase 1 study. This is an ASCO Meeting Abstract from the 2025 ASCO Annual Meeting I. This abstract does not ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results